SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
St. Jude Medical, Inc. (STJ) trades at a trailing P/E of 26.3. Trailing earnings yield is 3.80%.
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Trailing Earnings Yield 3.80% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 63/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — STJ
Valuation Multiples
P/E (TTM)26.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio4.18
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3.07
Book Value / Share$0.00
Revenue / Share$19.35
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.80%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2006 |
$1.47 |
$913.51M |
$548.25M |
60% |
| 2007 |
$1.59 |
$1.04B |
$559.04M |
53.7% |
| 2008 |
$1.10 |
$1.17B |
$384.33M |
32.8% |
| 2009 |
$2.26 |
$1.25B |
$777.23M |
62% |
| 2010 |
$2.75 |
$5.16B |
$907.44M |
17.6% |
| 2011 |
$2.52 |
$5.61B |
$825.79M |
14.7% |
| 2012 |
$2.39 |
$5.5B |
$752M |
13.7% |
| 2013 |
$2.49 |
$5.5B |
$723M |
13.1% |
| 2014 |
$3.46 |
$5.62B |
$1B |
17.8% |
| 2015 |
$3.07 |
$5.54B |
$880M |
15.9% |
